View DividendEnimmune マネジメントマネジメント 基準チェック /04現在、CEO に関する十分な情報がありません。主要情報 最高経営責任者n/a報酬総額CEO給与比率n/aCEO在任期間no dataCEOの所有権n/a経営陣の平均在職期間データなし取締役会の平均在任期間データなし経営陣の近況Enimmune corporation, Annual General Meeting, Jun 12, 2024Mar 22No independent directors Nov 16No independent directors Apr 27Enimmune corporation, Annual General Meeting, Jun 21, 2022Apr 02すべての更新を表示Recent updatesNew minor risk - Shareholder dilution Sep 01Second quarter 2024 earnings released: NT$0.58 loss per share (vs NT$0.59 loss in 2Q 2023) Aug 18New minor risk - Share price stability Jul 03Enimmune corporation, Annual General Meeting, Jun 12, 2024Mar 22Full year 2023 earnings released: NT$3.40 loss per share (vs NT$3.88 loss in FY 2022) Mar 14New minor risk - Financial data availability Feb 27New minor risk - Revenue size Aug 13New minor risk - Market cap size Jul 23Full year 2022 earnings released: NT$3.88 loss per share (vs NT$0.79 loss in FY 2021) Apr 23No independent directors Nov 16Full year 2021 earnings released: NT$0.79 loss per share (vs NT$1.40 loss in FY 2020) May 02No independent directors Apr 27Enimmune corporation, Annual General Meeting, Jun 21, 2022Apr 02Full year 2020 earnings released: NT$1.40 loss per share (vs NT$1.29 loss in FY 2019) Apr 25New 90-day high: NT$51.70 Feb 20New 90-day low: NT$42.75 Dec 05New 90-day low: NT$43.10 Nov 12New 90-day low: NT$52.10 Sep 30Earnings released Aug 16CEO（最高経営責任者Enimmune CEOがいない、あるいは彼らに関するデータがない。View Ownership